Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $8.59 Analyst target: $10.57 Upside: 23.05%
Exagen Inc. develops and markets various test products based on its Cell-Bound Complement Activation Products technology under the AVISE brand name in the United States. The company is headquartered in Vista, California.
See the full interactive analysis & chart →Informational only — not investment advice.